Paranoid personality disorder
F60.0 (45576554)
Transsexualism
F64.0 (45542861)
Gender identity disorder, unspecified
F64.9 (45542862)
Dissocial personality disorder
F60.2 (45586248)
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,TARKEMMIN MÄÄRITTELEMÄTÖN]
2961A (2000402785)
Other nonorganic psychoses, Unspecified psychosis
2989X (2000402820)
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
3018X (2000402863)
Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence
3041A (2000402890)
Dependent personality disorder
F60.7 (45538075)
Affective psychoses, Manic-depressive psychosis, other and unspecified
2968A (2000402814)
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
3018D (2000402861)
Drug dependence, Unspecified drug dependence
3049X (2000402896)
Addiction caused by sedative and hypnotic continuous use
F13.25 (2000501772)
Addiction caused by several drugs in combination and by other psychoactive substances UNS
F19.29 (2000501898)
Emotionally unstable personality disorder, borderline condition
F60.31 (2000502023)
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: Unspecified
SMOKING-2-2-0 (2002330110)
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: Unspecified
SMOKING-2-3-0 (2002330113)
Personal history of self-harm
Z91.5 (45605173)
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
2961C (2000402787)
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]
2961E (2000402789)
Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]
3000A (2000402830)
Neurotic disorders, Neurotic depression
3004A (2000402844)
Alcohol dependence syndrome, Other and unspecified alcohol dependence
3039X (2000402887)
Poisoning by psychotropic agents, Phenothiazine-based tranquillisers
9691A (2000408563)
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
9694A (2000408566)
Suicide and self-inflicted poisoning by solid or liquid substances
E950A (2000409123)
Alcohol dependence currently abstinent, but staying in restrictive environment
F10.21 (2000501678)
Alcohol dependence is currently on clinically controlled discontinuation medication
F10.22 (2000501679)
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
F10.23 (2000501680)
Addiction relationship caused by sedatives and hypnotics currently independent
F13.20 (2000501767)
Addiction relationship caused by sedative and hypnotic active addiction
F13.24 (2000501771)
Mixed personality disorders
F61.0 (2000502024)
Gender identity assessment
IBZ08 (2001304082)
SMOKING - SMOKE2: yes - SMOKE3: current - SMOKE5: Unspecified
SMOKING-1-1-0 (2002330116)
Geriatric Psychiatry
27 (38004470)
Body height measure
50373000 (4177340)
Body mass index
60621009 (4245997)
Histrionic personality disorder
F60.4 (45538074)
Mental and behavioural disorders due to use of cannabinoids, harmful use
F12.1 (45557163)
Emotionally unstable personality disorder
F60.3 (45566852)
Bipolar affective disorder, current episode severe depression with psychotic symptoms
F31.5 (45586236)
Mixed and other personality disorders
F61 (45595913)
Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
X61 (45600199)
Other specific personality disorders
F60.8 (45600756)
Intentional self-harm by sharp object
X78 (45756450)
Personality disorders, Dependent personality disorder
3016A (2000402857)
Nondependent abuse of drugs, Alcohol abuse
3050A (2000402898)
Poisoning by psychotropic agents, Antidepressants
9690A (2000408562)
Poisoning by psychotropic agents, Other antipsychotics, neuroleptics and major tranquillisers
9693X (2000408565)
Alcohol depence active use
F10.24 (2000501681)
Alcohol dependence periodic alcoholism
F10.26 (2000501683)
Addiction caused by alcohol UNS
F10.29 (2000501684)
Relationship caused by opiates continuously used
F11.25 (2000501719)
Intoxication caused by sedatives and hypnotics uncomplicated
F13.00 (2000501759)
Addiction caused by sedative and hypnotic UNS
F13.29 (2000501774)
Acute and transient psychosis, unspecified without acute stress factor
F23.90 (2000501961)
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
F31.20 (2000501974)
Emotionally unstable personality disorder, impulsive
F60.30 (2000502022)
Consultation concerning a patient with self-harm intention
IAB07 (2001304024)
Psychiatric evaluation of working capacity and rehabilitation
IBB02 (2001304049)
Psychiatric treatment plan, extended/prolonged
ICB02 (2001304099)
Psychoeducation, individual
IEY01 (2001304220)
Psychological examination of need and possibilities to rehabilitation
R1220 (2001310175)
Procedure duration 150 to 179 minutes
ZXE17 (2001311407)
Social worker in multidisciplinary team
ZXY83 (2001311552)
Head nurse
Z2230 (2001311557)
Flank/axilla symptom/complaint
L05 (2002000630)
Nose symptom/complaint other
R08 (2002000889)
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: former
SMOKING-2-2-4 (2002330109)
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: never
SMOKING-2-3-5 (2002330114)
SMOKING - SMOKE2: yes - SMOKE3: current - SMOKE5: current
SMOKING-1-1-1 (2002330115)
hydrocortisone; local oral
A01AC03 (21600036)
Fungus identified in Specimen by Culture
580-1 (3000494)
Substance Use Disorder Rehabilitation Clinic/Center
261QR0405X (38004257)
Substance Use Disorder Rehabilitation Hospital Unit
276400000X (38004274)
Problems in relationship with spouse or partner
Z63.0 (45537661)
Personality disorder, unspecified
F60.9 (45538076)
Poisoning: Benzodiazepines
T42.4 (45551182)
Anxious [avoidant] personality disorder
F60.6 (45557213)
Palpitations
R00.2 (45558446)
Poisoning: Tricyclic and tetracyclic antidepressants
T43.0 (45565557)
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
F15.2 (45576515)
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
F15.1 (45581428)
Anankastic personality disorder
F60.5 (45591150)
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
F13.1 (45600705)
Other problems related to lifestyle
Z72.8 (45609965)
Buprenorphine [Presence] in Urine by Screen method
93494-3 (1001926)
Personality disorders, Alia definita
30188 (2000301768)
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
E9509 (2000306610)
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]
2959A (2000402778)
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,LIEVÄASTEINEN]
2961B (2000402786)
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]
2961D (2000402788)
Adjustment reaction, With predominant disturbance of other emotions[USEINA EMOTIONAALISINA OIREINA ILM.SOPEUTUMISHÄIRIÖ]
3092E (2000402937)
Pure hypercholesterolaemia
E78.01 (2000501514)
Alcohol-related acute intoxication uncomplicated
F10.00 (2000501668)
Alcohol-related acute intoxication with permanent or other somatic damage
F10.01 (2000501669)
Alcohol intoxication UNS
F10.09 (2000501676)
Alcohol dependence continuous use
F10.25 (2000501682)
Withdrawal symptoms caused by alcohol uncomplicated
F10.30 (2000501685)
Addiction-induced dependence caused by opiates active addiction
F11.24 (2000501718)
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
F13.22 (2000501769)
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
F19.00 (2000501883)
Intoxication caused by several drugs in combination and by other psychoactive substances UNS
F19.09 (2000501890)
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
F19.20 (2000501891)
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
F19.21 (2000501892)
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
F19.24 (2000501895)
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
F19.25 (2000501896)
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated
F19.30 (2000501899)
Paranoid schizophrenia continuous
F20.00 (2000501920)
Paranoid schizophrenia UNS
F20.09 (2000501927)
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
F25.10 (2000501966)
Bipolar disorder depressive episode with somatic syndrome
F31.31 (2000501977)
Mild depressive episode without somatic syndrome
F32.00 (2000501978)
Moderate depressive episode with somatic syndrome
F32.11 (2000501981)
Recurrent depression, mild episode without somatic syndrome
F33.00 (2000501982)
Recurrent depression, mild episode of somatic syndrome
F33.01 (2000501983)
Recurrent depression, severe episode without somatic syndrome
F33.30 (2000501986)
Agoraphobia without concomitant panic disorder
F40.00 (2000501992)
Agoraphobia with concomitant panic disorder
F40.01 (2000501993)
Moderate panic disorder
F41.00 (2000501994)
Severe panic disorder
F41.01 (2000501995)
UNS Panic Syndrome
F41.09 (2000501997)
Acute stress reaction moderate
F43.01 (2000501999)
Adaptation disorder with short-term depression
F43.20 (2000502001)
Adaptation disorder with prolonged depression
F43.21 (2000502002)
Adaptation disorder UNS
F43.29 (2000502008)
Other definite dissociation disorder
F44.88 (2000502012)
Other childhood emotional disorders
F93.89 (2000502046)
Pulpit UNS
K04.09 (2000502704)
Periodontitis pronounced
K05.31 (2000502729)
Other leisure activity accident
Y94.8 (2000503731)
Standard MRI examination of brain with high intensity magnet
AA1BG (2001300112)
Lumbar puncture
TAB00 (2001300538)
Electroconvulsive therapy
AA400 (2001300694)
Intraoral radiographic dental examination
EB1AA (2001301903)
Extraction of root of tooth
EBA30 (2001301929)
ECG with 12 standard connections
XF400 (2001303368)
Assessment of need for psychiatric treatment
IAA01 (2001304011)
Consultation concerning further psychiatric treatment
IAA02 (2001304012)
Consultation concerning a patient who has attempted suicide
IAB08 (2001304025)
Psychiatric consultation in another specialty
IAZ97 (2001304038)
Diagnostic and symptom-mapping evaluation
IBA01 (2001304043)
Evaluation of need for psychiatric rehabilitation
IBA02 (2001304044)
Extensive initial psychiatric evaluation
IBA04 (2001304046)
Evaluation concerning developmental neuropsychiatry
IBZ06 (2001304080)
Psychiatric treatment plan, standard
ICB01 (2001304098)
Psychiatric treatment plan, monitoring
ICB03 (2001304100)
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
ICC01 (2001304102)
Psychiatric treatment plan, transfer to psychiatric ward
ICC03 (2001304104)
Psychiatric treatment plan, permanent discontinuation
ICC04 (2001304105)
Participation in compiling a psychiatric treatment plan
ICZ03 (2001304119)
Systematic group therapy, dialectical behavioral therapy (DKT), skill group
IDR19 (2001304155)
Systematic individual therapy, cognitive-behavioural
IDY03 (2001304164)
Psychoeducation, group
IER01 (2001304205)
Dedicated profession-specific psychiatric intervention, group
IER02 (2001304206)
Rehabilitative psychiatric group intervention, functional
IER04 (2001304208)
Rehabilitative psychiatric group intervention, social skills
IER05 (2001304209)
Other psychiatric network intervention
IEV99 (2001304218)
Psychiatric coaching, domestic and community skills
IEY08 (2001304227)
Electroconvulsive Therapy (ECT)
IFB01 (2001304301)
Psychiatric network contact
IGV01 (2001304319)
Accelerated psychiatric treatment contact
IGY01 (2001304321)
Laparoscopic excision or destruction of lesion of peritoneum
JAL21 (2001304497)
Insertion of nasogastric or naso-gastroduodenal tube
TJD00 (2001304797)
Simple extraction of IUD
TLC02 (2001306648)
Cathetrisation of vein
TPH04 (2001309597)
Occupational therapy
R4120 (2001310234)
Psychotherapy
R4140 (2001310238)
Other therapy enhancing rehabilitation
R4160 (2001310240)
Basic examination of mouth
SAA02 (2001310275)
Inhalation anesthesia
WX400 (2001310805)
Conventional respirator
WX730 (2001310831)
Planned therapy visit for psychiatric disease
W0A12 (2001310894)
Procedure duration 0 to 9 minutes
ZXE01 (2001311395)
Procedure duration 50 to 59 minutes
ZXE06 (2001311400)
Procedure duration 120 to 149 minutes
ZXE15 (2001311406)
Chief Physician, Head of Department or Deputy Chief Physician
ZXY01 (2001311511)
2-person team, doctor-nurse
ZXY51 (2001311525)
2-person team, nurse-psychologist
ZXY56 (2001311530)
2-person team, nurses
ZXY60 (2001311534)
Doctor in multidisciplinary team
ZXY80 (2001311549)
Psychologist in multidisciplinary team
ZXY81 (2001311550)
Nurse in multidisciplinary team
ZXY82 (2001311551)
Social worker
Z2446 (2001311559)
Other healthcare associate professional
Z3229 (2001311561)
Emergency clinic
ZYD01 (2001311586)
Contact between professionals
ZYY01 (2001311592)
Other indirect service without contact with patient
ZYY79 (2001311594)
Hospital inpatient
ZY000 (2001311598)
Screening of depression or other psychiatric problem
SPAT1246 (2001700347)
Extensive health certificate
SPAT1284 (2001700385)
General health counselling
SPAT1312 (2001700413)
Fear of other disease NOS
A27 (2002000161)
General and Unspecified, Result test/procedure
A60 (2002000194)
Abdominal pain epigastric
D02 (2002000301)
Rectal/anal pain
D04 (2002000303)
Gastroenteritis presumed infection
D73 (2002000371)
Chest symptom/complaint
L04 (2002000629)
Musculoskeletal sympt/complt other
L29 (2002000648)
Fear of mental disorder
P27 (2002000821)
Urine symptom/complaint other
U07 (2002001142)
Pregnancy
W78 (2002001269)
Abortion induced
W83 (2002001274)
clotrimazole; local oral
A01AB18 (21600028)
insulin (human); parenteral
A10AB01 (21600715)
insulin lispro; parenteral
A10AB04 (21600718)
insulin lispro; parenteral
A10AC04 (21600726)
insulin (human); parenteral
A10AD01 (21600729)
insulin (beef); parenteral
A10AD02 (21600730)
insulin lispro; parenteral
A10AD04 (21600732)
insulin glargine; parenteral
A10AE04 (21600739)
insulin detemir; parenteral
A10AE05 (21600740)
tolterodine; oral
G04BD07 (21602640)
glucagon; nasal, parenteral
H04AA01 (21602778)
doxycycline; oral, parenteral
J01AA02 (21602800)
amoxicillin; oral, parenteral
J01CA04 (21602823)
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 (21602863)
ipratropium bromide; inhalant
R03BB01 (21603293)
levomepromazine; oral, parenteral
N05AA02 (21604493)
perphenazine; oral, parenteral, rectal
N05AB03 (21604502)
asenapine; sublingual
N05AH05 (21604545)
paliperidone; oral, parenteral
N05AX13 (21604563)
nitrazepam; oral
N05CD02 (21604637)
paroxetine; oral
N06AB05 (21604713)
mianserin; oral
N06AX03 (21604732)
trazodone; oral
N06AX05 (21604734)
disulfiram; oral
N07BB01 (21604821)
metronidazole; oral, rectal
P01AB01 (21604857)
Elastase.pancreatic [Mass/mass] in Stool
25907-7 (3000570)
Benzodiazepines [Presence] in Urine
3390-2 (3000764)
Hemoglobin [Mass/volume] in Arterial blood
30313-1 (3002173)
Base excess in Arterial blood by calculation
1925-7 (3003396)
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 (3005785)
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 (3006217)
Campylobacter sp identified in Tissue by Organism specific culture
20740-7 (3006418)
Hepatitis B virus core IgM Ab [Presence] in Serum
31204-1 (3013527)
Fractional oxyhemoglobin in Arterial blood
2714-4 (3014007)
Lactate [Moles/volume] in Serum or Plasma
2524-7 (3014111)
Oxygen saturation in Arterial blood
2708-6 (3016502)
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 (3016543)
Cocaine [Presence] in Urine
3397-7 (3016879)
Gas panel - Arterial blood
24336-0 (3019060)
pH of Arterial blood
2744-1 (3019977)
Acetaminophen [Moles/volume] in Serum or Plasma
14581-3 (3020485)
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 (3021337)
Opiates [Presence] in Urine
3879-4 (3027008)
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 (3027475)
Oxygen [Partial pressure] in Arterial blood
2703-7 (3027801)
Amphetamines [Presence] in Urine
3349-8 (3027944)
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 (3027946)
Cannabinoids [Presence] in Urine
3427-2 (3028300)
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 (3028653)
Methadone [Presence] in Urine by Screen method
19550-3 (3028707)
Potassium [Moles/volume] in Arterial blood
32713-0 (3043409)
Calprotectin [Mass/mass] in Stool
38445-3 (3048689)
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 (36031861)
Rehabilitation Hospital
283X00000X (38004285)
Spirometry for bronchospasm with prolonged evaluation after bronchodilator
113016006 (4010399)
Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
56764-4 (40759883)
Shigella sp [Presence] in Stool by Culture
82300-5 (42529406)
Adjustment disorders
F43.2 (45533108)
Open wound of forearm, part unspecified
S51.9 (45535111)
Other stressful life events affecting family and household
Z63.7 (45537662)
Bipolar affective disorder, current episode hypomanic
F31.0 (45542840)
Hypomania
F30.0 (45547702)
Neuralgia and neuritis, unspecified
M79.2 (45548502)
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83 (45552036)
Observation for suspected mental and behavioural disorders
Z03.2 (45552060)
Observation for suspected disease or condition, unspecified
Z03.9 (45552062)
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
F19.1 (45552459)
Reaction to severe stress, unspecified
F43.9 (45552484)
Somatization disorder
F45.0 (45552486)
Fibromyalgia
M79.7 (45553272)
Elevated blood glucose level
R73 (45553744)
Carrier of viral hepatitis
Z22.5 (45556821)
Bacterial pneumonia, unspecified
J15.9 (45557621)
Nonallergic asthma
J45.1 (45557625)
Type 2 diabetes mellitus, with unspecified complications
E11.8 (45561951)
Mild depressive episode
F32.0 (45562041)
Recurrent depressive disorder, current episode severe with psychotic symptoms
F33.3 (45562042)
Cyclothymia
F34.0 (45562043)
Panic disorder [episodic paroxysmal anxiety]
F41.0 (45562047)
Epilepsy, unspecified
G40.9 (45562083)
Bipolar affective disorder, current episode mild or moderate depression
F31.3 (45571755)
Bipolar affective disorder, unspecified
F31.9 (45571758)
Multiple open wounds of forearm
S51.7 (45573714)
Obesity, unspecified
E66.9 (45576460)
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
F10.2 (45576496)
Mental and behavioural disorders due to use of opioids, harmful use
F11.1 (45576498)
Bipolar affective disorder, current episode manic without psychotic symptoms
F31.1 (45576537)
Recurrent depressive disorder
F33 (45576542)
Outcome of delivery
Z37 (45581024)
Psychotherapy, not elsewhere classified
Z50.4 (45581040)
Bipolar affective disorder, current episode severe depression without psychotic symptoms
F31.4 (45581456)
Depressive conduct disorder
F92.0 (45581477)
Acute bronchitis
J20 (45581849)
Intentional self-harm by unspecified means
X84 (45585673)
Schizotypal disorder
F21 (45586232)
Other acute predominantly delusional psychotic disorders
F23.3 (45586234)
Other bipolar affective disorders
F31.8 (45586237)
Dysthymia
F34.1 (45586238)
Mixed disorder of conduct and emotions, unspecified
F92.9 (45586263)
Bacterial infection, unspecified
A49.9 (45590816)
Chronic viral hepatitis C
B18.2 (45590846)
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 (45595844)
Undifferentiated schizophrenia
F20.3 (45595896)
Bipolar affective disorder
F31 (45595902)
Depressive episode
F32 (45595904)
Migraine, unspecified
G43.9 (45595943)
Irritable bowel syndrome with diarrhoea
K58.0 (45596336)
Other chest pain
R07.3 (45597166)
Anaemia, unspecified
D64.9 (45600610)
Persistent mood [affective] disorder, unspecified
F34.9 (45600741)
Obsessive-compulsive disorder, unspecified
F42.9 (45600745)
Atypical bulimia nervosa
F50.3 (45600752)
Other and unspecified convulsions
R56.8 (45602033)
Predominantly obsessional thoughts or ruminations
F42.0 (45605493)
Dissociative [conversion] disorder, unspecified
F44.9 (45605495)
Persistent somatoform pain disorder
F45.4 (45605498)
Gonarthrosis, unspecified
M17.9 (45606128)
Trochanteric bursitis
M70.6 (45606304)
Tachycardia, unspecified
R00.0 (45606790)
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
F15.5 (45755382)
Fall on and from stairs and steps
W10 (45756250)
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
X44 (45756400)
Exposure to unspecified factor
X59 (45756412)
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 (46237023)
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 (45585661)
Poisoning by systemic antibiotics
T36 (45756588)
Recurrent depression, moderate episode without somatic syndrome
F33.10 (2000501984)
chlorprothixene; oral, parenteral
N05AF03 (21604533)
Severe depressive episode with psychotic symptoms
F32.3 (45600739)
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 (45547705)
Post-traumatic stress disorder
F43.1 (45595909)
Bipolar affective disorder, current episode mixed
F31.6 (45571757)
Moderate depressive episode without somatic syndrome
F32.10 (2000501980)
Unspecified mood [affective] disorder
F39 (45591137)
Recurrent depressive disorder, unspecified
F33.9 (45581458)
Severe depressive episode without psychotic symptoms
F32.2 (45557202)
venlafaxine; oral
N06AX16 (21604745)
Anxiety disorder, unspecified
F41.9 (45542849)
Bipolar disorder Depressive episode without somatic syndrome
F31.30 (2000501976)
oxazepam; oral
N05BA04 (21604569)
buspirone; oral
N05BE01 (21604601)
valproic acid; oral, parenteral, rectal
N03AG01 (21604422)
Recurrent depression, moderate episode of somatic syndrome
F33.11 (2000501985)
lithium; oral
N05AN01 (21604556)
lamotrigine; oral
N03AX09 (21604431)
thioridazine; oral
N05AC02 (21604512)
quetiapine; oral
N05AH04 (21604544)
moclobemide; oral
N06AG02 (21604727)
General psychiatric examination, not elsewhere classified
Z00.4 (45605094)
risperidone; oral, parenteral
N05AX08 (21604559)
Dedicated profession-specific psychiatric intervention, individual
IEY05 (2001304224)
lorazepam; oral, parenteral, sublingual
N05BA06 (21604571)
Bulimia nervosa
F50.2 (45581464)
Atypical anorexia nervosa
F50.1 (45586245)
fluvoxamine; oral
N06AB08 (21604716)
olanzapine; oral, parenteral
N05AH03 (21604543)
Psychiatric pharmacotherapy plan, not specified
IFA01 (2001304251)
diazepam; oral, parenteral, rectal
N05BA01 (21604566)
Psychologist
Z2445 (2001311558)
mirtazapine; oral
N06AX11 (21604740)
olanzapine and samidorphan
N05AH53 (955100)
Depressive episode, unspecified
F32.9 (45571760)
temazepam; oral
N05CD07 (21604642)
Other psychiatric treatment contact
IGY99 (2001304323)
flupentixol; oral, parenteral
N05AF01 (21604531)
Severe psychotic and other severe mental disorders
112 (2001600112)
doxepin; oral, parenteral
N06AA12 (21604699)
Psychiatric monitoring contact
IGY02 (2001304322)
Lithium [Moles/volume] in Serum or Plasma
14334-7 (3024666)
Hospital outpatient
ZY010 (2001311599)
ziprasidone; oral, parenteral
N05AE04 (21604529)
clonazepam; oral, parenteral
N03AE01 (21604415)
pregabalin; oral
N02BF02 (955152)
Addiction-induced dependence is currently independent but uses substitute intermittent medication
F11.22 (2000501716)
Bipolar affective disorder, currently in remission
F31.7 (45581457)
Chronic alcohol abuse
P15 (2002000811)
Recurrent depressive disorder, current episode moderate
F33.1 (45576543)
Procedure duration 10 to 19 minutes
ZXE02 (2001311396)
Inpatient Hospital
21 (8717)
haloperidol; oral, parenteral
N05AD01 (21604516)
chlorpromazine; oral, parenteral, rectal
N05AA01 (21604492)
Valproate [Moles/volume] in Serum or Plasma
14946-8 (3009466)
Emergency Room Visit
ER (9203)
aripiprazole; oral, parenteral
N05AX12 (21604562)
Unspecified nonorganic psychosis
F29 (45533099)
Social phobias
F40.1 (45595907)
agomelatine; oral
N06AX22 (21604750)
Delusional disorder
F22.0 (45581451)
Clinic/Center
261Q00000X (38004207)
Procedure duration 90 to 119 minutes
ZXE13 (2001311404)
citalopram; oral, parenteral
N06AB04 (21604712)
biperiden; oral, parenteral
N04AA02 (21604447)
Office Visit
OMOP4822458 (581477)
Alcohol dependence currently independent
F10.20 (2000501677)
trimipramine; oral, parenteral
N06AA06 (21604693)
Phosphatidylethanol [Mass/volume] in Blood
74661-0 (44816559)
Eating disorder, unspecified
F50.9 (45547713)
Recurrent depressive disorder, currently in remission
F33.4 (45533100)
Schizoaffective disorder, unspecified
F25.9 (45605490)
fluoxetine; oral
N06AB03 (21604711)
bupropion; oral
N06AX12 (21604741)
Procedure duration 60 to 89 minutes
ZXE11 (2001311402)
Drug abuse
P19 (2002000815)
chlordiazepoxide; oral, parenteral
N05BA02 (21604567)
Mixed obsessional thoughts and acts
F42.2 (45542850)
Profession-specific psychiatric evaluation
IBZ01 (2001304075)
Mixed anxiety and depressive disorder
F41.2 (45566845)
Generalized anxiety disorder
F41.1 (45571764)
Remote contact by phone
ZYC01 (2001311579)
alprazolam; oral
N05BA12 (21604577)
milnacipran; oral
N06AX17 (21604746)
Anorexia nervosa
F50.0 (45562053)
Mental disorder, not otherwise specified
F99 (45605525)
magnesium hydroxide; oral
A02AA04 (21600052)
magnesium hydroxide; oral
G04BX01 (21602658)
propranolol; oral, parenteral
C07AA05 (21601670)
clomipramine; oral, parenteral
N06AA04 (21604691)
Emergency Room and Inpatient Visit
ERIP (262)
escitalopram; oral
N06AB10 (21604718)
Psychological disorders other
P99 (2002000880)
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 (3003031)
Supplier / Service Provider
OMOP5117446 (33004)
Drugs identified in Urine by Screen method Nominal
12286-1 (3011288)
zopiclone; oral
N05CF01 (21604654)
Child and Adolescent Psychiatry
OMOP4821986 (45756756)
sertraline; oral
N06AB06 (21604714)
Methylenedioxymethamphetamine [Presence] in Urine by Screen method
19568-5 (3002148)
hydroxyzine; oral, parenteral
N05BB01 (21604590)
duloxetine; oral
N06AX21 (21604749)
buprenorphine; implant, parenteral, sublingual
N07BC01 (21604826)
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
F25.20 (2000501968)
Somatic assessment of psychiatric patient
IBZ02 (2001304076)
Outpatient Visit
OP (9202)
Disturbance of activity and attention
F90.0 (45542870)
atomoxetine; oral
N06BA09 (21604762)
Predominantly compulsive acts [obsessional rituals]
F42.1 (45591138)
Other eating disorders
F50.8 (45581465)
Other specified anxiety disorders
F41.8 (45595908)
Emergency Medicine
93 (38004510)
Personality disorder
P80 (2002000874)
Monitored bed care
WX892 (2001310850)
buprenorphine; parenteral, sublingual, transdermal
N02AE01 (21604287)
Other mixed anxiety disorders
F41.3 (45605492)
reboxetine; oral
N06AX18 (21604747)
sertindole; oral
N05AE03 (21604528)
Asperger syndrome
F84.5 (45576562)
Other intensified psychiatric treatment
IEY21 (2001304240)
Depressive disorder
P76 (2002000870)
Medication abuse
P18 (2002000814)
Schizophrenia, unspecified
F20.9 (45576533)
Moderate depressive episode
F32.1 (45552478)
sulpiride; oral, parenteral
N05AL01 (21604548)
Adaptation disorder with mixed anxiety and depression
F43.22 (2000502003)
zolpidem; oral
N05CF02 (21604655)
Withdrawal symptoms caused by alcohol UNS
F10.39 (2000501687)
Phobic anxiety disorder, unspecified
F40.9 (45542848)
Anxiety disorder/anxiety state
P74 (2002000868)
clopenthixol; oral, parenteral
N05AF02 (21604532)
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 (3026910)
Folate [Moles/volume] in Red Blood Cells
14731-4 (3019309)
naltrexone; oral
N07BB04 (21604824)
vortioxetine; oral
N06AX26 (44819158)
Other recurrent depressive disorders
F33.8 (45600740)
Thorax X-ray examination outside radiological department
GD1UA (2001303652)
Physiotherapist
Z3226 (2001311560)
Drug use
Z72.2 (45571385)
methylphenidate; oral
N06BA04 (21604757)
Internal Medicine
11 (38004456)
Observation for suspected nervous system disorder
Z03.3 (45609903)
Outpatient Hospital
22 (8756)
Acute alcohol abuse
P16 (2002000812)
lurasidone; oral
N05AE05 (43534827)
carbamazepine; oral, rectal
N03AF01 (21604417)
Other psychiatric rehabilitation intervention
IEZ99 (2001304248)
Drug screening
SPAT1272 (2001700373)
macrogol; oral
A06AD15 (21600575)
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 (3007628)
Other nonorganic psychotic disorders
F28 (45605491)
Urine methamphetamine measurement
313579004 (4198724)
Undifferentiated schizophrenia continuous
F20.30 (2000501944)
Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)
IEY02 (2001304221)
lactulose; oral
A06AD11 (21600571)
amitriptyline and psycholeptics
N06CA01 (21604789)
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
F25.00 (2000501964)
Suture of skin of upper limb
QCB00 (2001309902)
Undifferentiated schizophrenia UNS
F20.39 (2000501951)
General Practice
1 (38004446)
Other depressive episodes
F32.8 (45571759)
Supervision of high-risk pregnancy due to social problems
Z35.7 (45561625)
Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms
F25.11 (2000501967)
pH of Specimen
17433-4 (3019225)
Anesthesiology Critical Care Medicine
OMOP4821991 (45756751)
Other specified intervertebral disc degeneration
M51.3 (45591865)
Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms
F25.21 (2000501969)
melatonin; oral
N05CH01 (21604659)
Care involving use of other rehabilitation procedures
Z50.8 (45556842)